Journal details
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
AMER ASSOC CANCER RESEARCH · ISSN 1055-9965 · eISSN 1538-7755
SCIEScopusMEDLINEPubMedPMC
Overview
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION is a Oncology · Public, Environmental & Occupational Health journal published by AMER ASSOC CANCER RESEARCH (United States). Use this page to check its impact factor, JCR quartile, CAS zone and indexing before you submit. Always confirm the scope, APC and policies on the journal's official website.
Publication output
2026: 129 articles · 2025: 864 articles · 2024: 764 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION?
The impact factor recorded for CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION is 3.7 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION?
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION is listed in CAS Zone 2.
Which databases index CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION?
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.